Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

aTYR PHARMA (ATYR) Current Leases (2019 - 2025)

Historic Current Leases for aTYR PHARMA (ATYR) over the last 7 years, with Q3 2025 value amounting to $799000.0.

  • aTYR PHARMA's Current Leases rose 1698.39% to $799000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $799000.0, marking a year-over-year increase of 1698.39%. This contributed to the annual value of $711000.0 for FY2024, which is 1444.04% down from last year.
  • Per aTYR PHARMA's latest filing, its Current Leases stood at $799000.0 for Q3 2025, which was up 1698.39% from $769000.0 recorded in Q2 2025.
  • aTYR PHARMA's Current Leases' 5-year high stood at $1.0 million during Q1 2022, with a 5-year trough of $420000.0 in Q1 2023.
  • Moreover, its 5-year median value for Current Leases was $769000.0 (2025), whereas its average is $767157.9.
  • As far as peak fluctuations go, aTYR PHARMA's Current Leases plummeted by 5849.8% in 2023, and later skyrocketed by 4976.19% in 2024.
  • Over the past 5 years, aTYR PHARMA's Current Leases (Quarter) stood at $980000.0 in 2021, then plummeted by 35.71% to $630000.0 in 2022, then surged by 31.9% to $831000.0 in 2023, then fell by 14.44% to $711000.0 in 2024, then rose by 12.38% to $799000.0 in 2025.
  • Its Current Leases was $799000.0 in Q3 2025, compared to $769000.0 in Q2 2025 and $740000.0 in Q1 2025.